FIELD: medicine.
SUBSTANCE: invention represents a composition for treating burns containing oxidised dextran with molecular weight 35-65 kDa, an antiseptic, an anaesthetic, nanodiamonds with particle size 4-10 nm and a pharmaceutically acceptable filling agent with the ingredients in the composition are taken in certain proportions, wt %.
EFFECT: invention provides the high therapeutic efficacy in treating burns and the lower risk of developing complications.
4 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| WOUND-HEALING MEANS | 2017 |
|
RU2644255C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING BURNS | 2012 |
|
RU2473349C1 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| PHARMACEUTICAL COMPOSITION FOR IMMEDIATE TREATMENT OF BURNS OF VARIOUS ORIGINS, AREA AND DEPTH IN FORM OF SPRAY, GEL AND AEROSOL | 2014 |
|
RU2545798C1 |
| ANTISEPTIC COMBINATION, ANTISEPTIC PHARMACEUTICAL COMPOSITION AND THEIR USE | 2022 |
|
RU2797957C1 |
| ANTISEPTIC COMBINATION, ANTISEPTIC PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2021 |
|
RU2774622C1 |
| SUBSTANCE OF PROTEOLITHIC FERMENT BASED ON PROTOSUBTILIN GZH IMMOBILIZED ON CHITOSAN AND COMPOSITION FOR TREATMENT OF PURULENT-NECROTIC WOUNDS | 2016 |
|
RU2630668C1 |
| COMPOSITION FOR WOUND TREATMENT AND PRODUCTS ON ITS BASIS | 2011 |
|
RU2467767C1 |
| INTRANASAL DRUG FOR INFLUENZA PREVENTION | 2017 |
|
RU2634250C1 |
| METHOD OF TREATING BURNS IN ANIMALS | 2022 |
|
RU2808182C1 |
